tiprankstipranks
Atea Pharmaceuticals (AVIR)
NASDAQ:AVIR
US Market

Atea Pharmaceuticals (AVIR) Technical Analysis

Compare
212 Followers

Technical Sentiment

Overall Consensus
Buy
10Bullish
5Neutral
7Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Atea Pharmaceuticals’s (AVIR) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting Atea Pharmaceuticals is a Sell.
Atea Pharmaceuticals’s (AVIR) 20-Day exponential moving average is 3.10, while Atea Pharmaceuticals’s (AVIR) share price is $3.14, making it a Buy.
Atea Pharmaceuticals’s (AVIR) 50-Day exponential moving average is 3.17, while Atea Pharmaceuticals’s (AVIR) share price is $3.14, making it a Sell.

Atea Pharmaceuticals (AVIR) Pivot Points

Feb 22, 2025, 01:13 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.94
2.99
3.04
3.09
3.14
3.19
3.24
Fibonacci
2.99
3.03
3.05
3.09
3.13
3.15
3.19
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Atea Pharmaceuticals (AVIR) Moving Averages

Feb 22, 2025, 01:13 PM
Period
Simple
Exponential
MA5
3.12Buy
3.11Buy
MA10
3.08Buy
3.10Buy
MA20
3.07Buy
3.10Buy
MA50
3.15Sell
3.17Sell
MA100
3.27Sell
3.28Sell
MA200
3.47Sell
3.46Sell
Atea Pharmaceuticals’s (AVIR) 10-Day exponential moving average is 3.10, while Atea Pharmaceuticals’s (AVIR) share price is $3.14, making it a Buy.
Atea Pharmaceuticals’s (AVIR) 100-Day exponential moving average is 3.28, while Atea Pharmaceuticals’s (AVIR) share price is $3.14, making it a Sell.
Atea Pharmaceuticals’s (AVIR) stock price is $3.14 and Atea Pharmaceuticals’s (AVIR) 50-day simple moving average is 3.15, creating a Sell signal.
Atea Pharmaceuticals’s (AVIR) stock price is $3.14 and Atea Pharmaceuticals’s (AVIR) 100-day simple moving average is 3.27, creating a Sell signal.
Atea Pharmaceuticals’s (AVIR) stock price is $3.14 and Atea Pharmaceuticals’s (AVIR) 200-day simple moving average is 3.47, creating a Sell signal.

Atea Pharmaceuticals (AVIR) Technical Indicators

Feb 22, 2025, 01:13 PM
Name
Value
Implied Action
RSI (14)
51.36
Neutral
STOCH (9,6)
54.84
Neutral
STOCHRSI (14)
60.00
Neutral
MACD (12,26)
-0.02
Sell
ADX (14)
11.03
Buy
Williams %R
-31.43
Buy
CCI (14)
72.21
Neutral
ATR (14)
0.14
-
Ultimate Oscillator
40.70
Neutral
ROC
5.02
Buy
Atea Pharmaceuticals’s (AVIR) Relative Strength Index (RSI) is 51.36, creating a Neutral signal.
Atea Pharmaceuticals’s (AVIR) Trend Strength Indicator (ADX) is 11.03, creating a Buy signal.
Atea Pharmaceuticals’s (AVIR) Commodity Channel Index (CCI) is 72.21, creating a Neutral signal.
Atea Pharmaceuticals’s (AVIR) Price Rate of Change (ROC) is 5.02, creating a Buy signal.

FAQ

Is AVIR a Buy, Hold, or Sell?
Based on AVIR’s technical indicators, AVIR is a Buy.
    What is AVIR’s RSI (14)?
    AVIR’s RSI (14) is 51.36, which suggests AVIR is a Neutral.
      What is AVIR’s MACD?
      AVIR’s MACD is -0.02, which suggests AVIR is a Sell.
        What is AVIR’s 5-day moving average?
        AVIR’s 5-day moving average is 3.12, which suggests AVIR is a Buy.
          What is AVIR’s 20-day moving average?
          AVIR 20-day moving average is 3.07, which suggests AVIR is a Buy.
            What is AVIR’s 50-day moving average?
            AVIR’s 50-day moving average is 3.15, which suggests AVIR is a Sell.
              What is AVIR’s 200-day moving average?
              AVIR’s 200-day moving average is 3.47, which suggests AVIR is a Sell.
                What is AVIR’s Williams % R (14)?
                AVIR’s Williams % R (14) is -31.43, which suggests AVIR is a Buy.
                  What is AVIR’s CCI (14)?
                  AVIR’s CCI (14) is 72.21, which suggests AVIR is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis